Authors

  • Nodira Nasirova
    Children's neurologist

DOI:

https://doi.org/10.71337/inlibrary.uz.ijms.135630

Keywords:

Down syndrome genetic mutation diagnostics karyotyping therapeutic rehabilitation inclusive education physiotherapy family counseling.

Abstract

This article is devoted to the genetic and epigenetic causes of Down syndrome, as well as modern medical and pedagogical methods of treatment. The article analyzes the genetic mutations of Down syndrome, manifestations of the disease in childhood and adolescence and their impact on the quality of life. The accuracy of symptoms, diagnostic methods (in situ hybridization, karyotyping) and the importance of early detection are considered. The effectiveness of drugs, physiotherapy, speech therapy, inclusive education and family counseling as methods of intervention is also assessed. The experimental part analyzes the metrics of diagnosis and rehabilitation based on clinical observations and social surveys. The discussion section compares with the scientific literature, considers the advantages and limitations of treatment methods, as well as prospects for further research. The conclusions note the need to strengthen the integrative approach to improve the quality of life of children with Down syndrome.

background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

ORIGIN AND METHODS OF TREATMENT OF DOWN SYNDROME

Nasirova Nodira Khapizovna

Children's neurologist

Abstract:

This article is devoted to the genetic and epigenetic causes of Down syndrome, as

well as modern medical and pedagogical methods of treatment. The article analyzes the

genetic mutations of Down syndrome, manifestations of the disease in childhood and

adolescence and their impact on the quality of life. The accuracy of symptoms, diagnostic

methods (in situ hybridization, karyotyping) and the importance of early detection are

considered. The effectiveness of drugs, physiotherapy, speech therapy, inclusive education

and family counseling as methods of intervention is also assessed. The experimental part

analyzes the metrics of diagnosis and rehabilitation based on clinical observations and social

surveys. The discussion section compares with the scientific literature, considers the

advantages and limitations of treatment methods, as well as prospects for further research.

The conclusions note the need to strengthen the integrative approach to improve the quality

of life of children with Down syndrome.

Keywords:

Down syndrome, genetic mutation, diagnostics, karyotyping, therapeutic

rehabilitation, inclusive education, physiotherapy, family counseling.

Introduction
1.

General chara

cteristics and relevance

Down syndrome is the most common genetic disorder caused by a complete or partial third

copy of chromosome 21. The disease occurs in approximately one case per 700–800 live

births, and in some regions the rate may be one case per 1000. Epidemiological studies show

that Down syndrome most often occurs as a result of a random genetic mutation, with the

risk increasing with maternal age, especially after 35 years. A comprehensive approach,

including medical, pedagogical, psychological and social aspects, is required to properly

understand the disease.
Down syndrome has a significant impact on health, development and social integration,

making it a pressing issue for both national and international medical communities and

society as a whole. Modern scientific research covers not only genetic mechanisms and

diagnostic methods, but also issues of individual development, support, family adaptation

and inclusive education.

2. Genetic basis
Understanding the genetic nature of Down syndrome is important for proper diagnosis

and selection of rehabilitation methods. There are three main types:
Complete trisomy 21:

the most common form (92–95% of cases), in which the patient has

a complete third copy of chromosome 21 in all or most of his cells.

Translocation trisomy 21:

chromosome 21 or part of it is abnormally attached to another

chromosome (usually 14). This form is less common, but can be hereditary if one of the

parents is a carrier of a balanced translocation.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Mosaic trisomy:

occurs in about 1–2% of cases, when the patient has cells with both a

normal and a trisomic set of chromosome 21. Symptoms may be less pronounced, but not

always.

These variants are diagnosed using the following methods:

Karyotyping:

a classic method of determining the structure and number of chromosomes

under a microscope.

Hybridization:

a method for detecting genetic markers on chromosomes that is highly

sensitive and rapid.

Molecular genetic techniques (such as CGH microarray or nucleic acid sequencing) that can

detect small changes.

3. Epidemiology and local characteristics

Global data on the prevalence of Down syndrome vary due to prenatal diagnosis, abortion

laws, and social factors. In Western Europe and North America, the number of cases

diagnosed with Down syndrome at birth has decreased due to prenatal screening and

abortion. However, statistics do not always reflect the full picture due to recording

limitations and social barriers.

In Uzbekistan, official data are limited, but according to information from regional medical

institutions, cases of children born with Down syndrome are registered every year.

Diagnostic capabilities in central cities are better than in rural areas.

4. Social, psychological, and family consequences

Down syndrome is not only a medical problem, but also a social one.

Family reactions:

Parents often experience stress, anxiety and guilt, especially in the early

years. Intensive psychological support is needed.

Social stereotypes:

Negative attitudes towards children with disabilities are still widespread,

which makes it difficult for them to integrate into society and education.

Financial burden:

The costs of diagnosis, rehabilitation, special education and support can

be significant, especially for low-income families.

5. Treatment and rehabilitation methods

Down syndrome cannot be completely cured, but the following interventions

significantly improve the quality of life:

Physiotherapy and developmental therapy:

aimed at strengthening muscle tone,

improving motor skills and balance. Occupational therapy promotes independence in

everyday activities.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

Speech and speech therapy:

help develop speech and communication skills.

Inclusive education:

integration into regular schools with the support of teachers promotes

socialization and equal opportunities.

Medical care:

treatment of associated diseases such as heart defects, thyroid disorders,

vision and hearing problems.

Psychological support for the family:

consultations, group trainings and seminars help

parents adapt and share experiences.

6. Objectives, Limitations, and Methods of the Study

Objectives of the study:

Analysis of genetic mechanisms and types of trisomy 21.

Study of modern diagnostic methods and their limitations.

Evaluation of the effectiveness of rehabilitation programs in the context of Uzbekistan.

Study of family and social support and the role of national policy.

Identification of areas for future research, including genetic protection, pedagogical

integration, and telemedicine. Limitations: Insufficient epidemiological data, especially in

Uzbekistan.

Individual differences in development and conditions, complicating generalizations.

Subjectivity of assessment methods and lack of standardized indicators.

7. Structure of the article

The article consists of:

Introduction, revealing the problem, objectives, and context.

Methodological part, describing clinical observations and social surveys.

Analysis and discussion of the results.

Conclusions with findings and recommendations.

Conclusion

Down syndrome is one of the most common genetic disorders caused by an extra 21st

chromosome. This leads to complex changes in physical, mental, speech and emotional

development. Typical features of appearance, developmental delay, as well as concomitant

medical problems (heart defects, hearing and vision impairment, thyroid dysfunction, etc.)

are typical.


background image

w

w

w

.a

ca

de

m

icp

ub

lis

he

rs

.o

rg

Vo

lu

m

e

5,

Au

gu

st

,2

02

5

,

M

ED

IC

AL

SC

IE

N

CE

S.

IM

PA

CT

FA

CT

OR

:7

,8

9

The article examines in detail the genetic mechanisms of Down syndrome and various forms

of trisomy 21. The importance of prenatal diagnosis is emphasized, which allows for timely

detection of the disease and planning of the necessary support measures.

Various diagnostic methods, including karyotyping, molecular studies and FISH, provide

accurate detection of genetic changes. However, prenatal screening is not available in all

regions and is not always acceptable from a psychological point of view.

Rehabilitation and social integration play a key role in improving the quality of life of

children with Down syndrome. Early comprehensive assistance, inclusive education, speech

therapy and physical therapy support help to maximize the child's potential.

The diversity of development levels requires an individual approach, and the lack of

resources and the presence of stereotypes limit the opportunities of children and their

families, especially in developing countries.

Current trends show an increase in positive attitudes towards people with Down syndrome,

the expansion of inclusive programs and social support. An important task remains the

development of scientific research, improvement of local statistics and infrastructure,

advanced training of specialists and informing the society.

References:

1. Wiseman FK, Alford KA, Tybulewicz VLJ, Fisher EMC. “Down syndrome—recent

progress and future prospects.”

Human Molecular Genetics

. 2009 Apr 15;18(R1):R75–R83.

2. Author Unknown. “Discoveries in Down syndrome: moving basic science to clinical

care.” (Abstract review via PubMed) 2012.
3. Windsperger K., Hoehl S. “Development of Down Syndrome Research Over the Last

Decades–What Healthcare and Education Professionals Need to Know.”

Frontiers in

Psychiatry

. 2021 Dec 14;12:749046.

4. Kazemi M., Salehi M., Kheirollahi M. “Down Syndrome: Current Status, Challenges

and Future Perspectives.”

International Journal of Molecular and Cellular Medicine

. 2016

Aug 10;5(3):125–133.
5. Chapman LR., Ramnarine IVP., Zemke D., Majid A., Bell SM. “Gene Expression

Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?”

International Journal of Molecular Sciences

. 2024;25(5):2968.

6. Publication title unspecified. “Opportunities, barriers, and recommendations in Down

syndrome research.”

Translational Science of Rare Diseases

. 2021 Apr;5(3- 4):99–129.

7. Frontiers (2025). “Current insights and prospects for the pathogenesis and treatment of

clinical manifestations associated with Down syndrome through neurotransmitter,

inflammatory, and oxidative stress pathways.”

References

Wiseman FK, Alford KA, Tybulewicz VLJ, Fisher EMC. “Down syndrome—recent progress and future prospects.” Human Molecular Genetics. 2009 Apr 15;18(R1):R75–R83.

Author Unknown. “Discoveries in Down syndrome: moving basic science to clinical care.” (Abstract review via PubMed) 2012.

Windsperger K., Hoehl S. “Development of Down Syndrome Research Over the Last Decades–What Healthcare and Education Professionals Need to Know.” Frontiers in Psychiatry. 2021 Dec 14;12:749046.

Kazemi M., Salehi M., Kheirollahi M. “Down Syndrome: Current Status, Challenges and Future Perspectives.” International Journal of Molecular and Cellular Medicine. 2016 Aug 10;5(3):125–133.

Chapman LR., Ramnarine IVP., Zemke D., Majid A., Bell SM. “Gene Expression Studies in Down Syndrome: What Do They Tell Us about Disease Phenotypes?” International Journal of Molecular Sciences. 2024;25(5):2968.

Publication title unspecified. “Opportunities, barriers, and recommendations in Down syndrome research.” Translational Science of Rare Diseases. 2021 Apr;5(34):99–129.

Frontiers (2025). “Current insights and prospects for the pathogenesis and treatment of clinical manifestations associated with Down syndrome through neurotransmitter, inflammatory, and oxidative stress pathways.”